ImmuneSpec

Foundation date

27/01/2023

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmuneSpec offers MHC associated peptide proteomics (MAPPS) as a service. We developed an advanced immunopeptidomics platform which allows fast & reliable identification of immunogenic peptides to pinpoint all peptide regions which evoke an immune response. Key applications include pinpointing immunogenic areas for the development of broad-spectrum vaccines, identification of neo-antigens for the generation of leads suitable for immunotherapy, and testing of biologics for unwanted immunogenicity.

Latest news

  • Researchers unravel complexities of Alzheimer’s disease in protein fragments and plaque diversity

    10 hours ago

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    1 day ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    1 day ago